Literature DB >> 21969102

Binding of novel fullerene inhibitors to HIV-1 protease: insight through molecular dynamics and molecular mechanics Poisson-Boltzmann surface area calculations.

Haralambos Tzoupis1, Georgios Leonis, Serdar Durdagi, Varnavas Mouchlis, Thomas Mavromoustakos, Manthos G Papadopoulos.   

Abstract

The objectives of this study include the design of a series of novel fullerene-based inhibitors for HIV-1 protease (HIV-1 PR), by employing two strategies that can also be applied to the design of inhibitors for any other target. Additionally, the interactions which contribute to the observed exceptionally high binding free energies were analyzed. In particular, we investigated: (1) hydrogen bonding (H-bond) interactions between specific fullerene derivatives and the protease, (2) the regions of HIV-1 PR that play a significant role in binding, (3) protease changes upon binding and (4) various contributions to the binding free energy, in order to identify the most significant of them. This study has been performed by employing a docking technique, two 3D-QSAR models, molecular dynamics (MD) simulations and the molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) method. Our computed binding free energies are in satisfactory agreement with the experimental results. The suitability of specific fullerene derivatives as drug candidates was further enhanced, after ADMET (absorption, distribution, metabolism, excretion and toxicity) properties have been estimated to be promising. The outcomes of this study revealed important protein-ligand interaction patterns that may lead towards the development of novel, potent HIV-1 PR inhibitors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969102     DOI: 10.1007/s10822-011-9475-4

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  56 in total

1.  Structure and thermodynamics of RNA-protein binding: using molecular dynamics and free energy analyses to calculate the free energies of binding and conformational change.

Authors:  C M Reyes; P A Kollman
Journal:  J Mol Biol       Date:  2000-04-14       Impact factor: 5.469

Review 2.  ADMET in silico modelling: towards prediction paradise?

Authors:  Han van de Waterbeemd; Eric Gifford
Journal:  Nat Rev Drug Discov       Date:  2003-03       Impact factor: 84.694

3.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.

Authors:  Araz Jakalian; David B Jack; Christopher I Bayly
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

4.  Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease.

Authors:  Hiroyasu Ohtaka; Adrian Velázquez-Campoy; Dong Xie; Ernesto Freire
Journal:  Protein Sci       Date:  2002-08       Impact factor: 6.725

5.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

6.  Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations.

Authors:  Darón I Freedberg; Rieko Ishima; Jaison Jacob; Yun-Xing Wang; Irina Kustanovich; John M Louis; Dennis A Torchia
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

7.  Linear and nonlinear optical properties of [60]fullerene derivatives.

Authors:  O Loboda; R Zaleśny; A Avramopoulos; J-M Luis; B Kirtman; N Tagmatarchis; H Reis; M G Papadopoulos
Journal:  J Phys Chem A       Date:  2009-01-15       Impact factor: 2.781

Review 8.  Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.

Authors:  Eric Lefebvre; Celia A Schiffer
Journal:  AIDS Rev       Date:  2008 Jul-Sep       Impact factor: 2.500

9.  Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation.

Authors:  S H Friedman; P S Ganapathi; Y Rubin; G L Kenyon
Journal:  J Med Chem       Date:  1998-06-18       Impact factor: 7.446

10.  HIV-1 protease substrate binding and product release pathways explored with coarse-grained molecular dynamics.

Authors:  Joanna Trylska; Valentina Tozzini; Chia-en A Chang; J Andrew McCammon
Journal:  Biophys J       Date:  2007-03-23       Impact factor: 4.033

View more
  8 in total

1.  Molecular simulation methods in drug discovery: a prospective outlook.

Authors:  Xavier Barril; F Javier Luque
Journal:  J Comput Aided Mol Des       Date:  2011-12-08       Impact factor: 3.686

2.  Exploring the drug resistance of V32I and M46L mutant HIV-1 protease to inhibitor TMC114: flap dynamics and binding mechanism.

Authors:  Biswa Ranjan Meher; Yixuan Wang
Journal:  J Mol Graph Model       Date:  2014-12-05       Impact factor: 2.518

3.  The influence of the configuration of the (C70)2 dimer on its rovibrational spectroscopic properties: a theoretical survey.

Authors:  Rodrigo A L Silva; Sandro F de Brito; Daniel F S Machado; Valter H Carvalho-Silva; Heibbe C B de Oliveira; Luciano Ribeiro
Journal:  J Mol Model       Date:  2018-08-15       Impact factor: 1.810

4.  Binding of single walled carbon nanotube to WT and mutant HIV-1 proteases: analysis of flap dynamics and binding mechanism.

Authors:  Biswa Ranjan Meher; Yixuan Wang
Journal:  J Mol Graph Model       Date:  2012-10-13       Impact factor: 2.518

5.  Exploration of the binding affinities between ecdysone agonists and EcR/USP by docking and MM-PB/GBSA approaches.

Authors:  Xueping Hu; Jin Xie; Song Hu; Li Zhang; Yanhong Dong
Journal:  J Mol Model       Date:  2017-04-24       Impact factor: 1.810

Review 6.  Molecular modeling in structural nano-toxicology: interactions of nano-particles with nano-machinery of cells.

Authors:  Naveena Yanamala; Valerian E Kagan; Anna A Shvedova
Journal:  Adv Drug Deliv Rev       Date:  2013-05-28       Impact factor: 15.470

7.  Advantages and limitations of classic and 3D QSAR approaches in nano-QSAR studies based on biological activity of fullerene derivatives.

Authors:  Karolina Jagiello; Monika Grzonkowska; Marta Swirog; Lucky Ahmed; Bakhtiyor Rasulev; Aggelos Avramopoulos; Manthos G Papadopoulos; Jerzy Leszczynski; Tomasz Puzyn
Journal:  J Nanopart Res       Date:  2016-08-29       Impact factor: 2.253

Review 8.  Nano-(Q)SAR for Cytotoxicity Prediction of Engineered Nanomaterials.

Authors:  Andrey A Buglak; Anatoly V Zherdev; Boris B Dzantiev
Journal:  Molecules       Date:  2019-12-11       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.